Invention Grant
- Patent Title: Biaryl ether sulfonamides and their use as therapeutic agents
-
Application No.: US14355549Application Date: 2012-10-30
-
Publication No.: US09365578B2Publication Date: 2016-06-14
- Inventor: Shifeng Liu , Thilo Focken , Navjot Chahal , Zaihui Zhang , Renata Marcella Oballa , Julia Fonarev
- Applicant: XENON PHARMACEUTICALS INC.
- Applicant Address: CA Burnaby, BC
- Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee Address: CA Burnaby, BC
- Agency: Viksnins Harris & Padys PLLP
- International Application: PCT/IB2012/056032 WO 20121030
- International Announcement: WO2013/064984 WO 20130510
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D417/12 ; C07D471/04 ; C07D473/00 ; C07D417/14 ; C07D403/12
Abstract:
This invention is directed to biaryl ether sulfonamides, or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.
Public/Granted literature
- US09481677B2 Biaryl ether sulfonamides and their use as therapeutic agents Public/Granted day:2016-11-01
Information query
